Wiltrom Co., Ltd. (TPEX:6767)
26.50
+0.20 (0.76%)
May 29, 2026, 12:36 PM CST
Wiltrom Revenue
Wiltrom had revenue of 82.37M TWD in the quarter ending March 31, 2026, with 0.81% growth. This brings the company's revenue in the last twelve months to 312.43M, down -7.67% year-over-year. In the year 2025, Wiltrom had annual revenue of 311.77M, down -6.86%.
Revenue (ttm)
312.43M
Revenue Growth
-7.67%
P/S Ratio
3.32
Revenue / Employee
n/a
Employees
51
Market Cap
1.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 311.77M | -22.96M | -6.86% |
| Dec 31, 2024 | 334.73M | 57.62M | 20.79% |
| Dec 31, 2023 | 277.11M | 70.25M | 33.96% |
| Dec 31, 2022 | 206.86M | 62.37M | 43.16% |
| Dec 31, 2021 | 144.50M | 42.13M | 41.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.81B |
| Cowealth Medical Holding | 2.86B |
| AViTA | 952.73M |
| Bioptik Technology Incorporation | 865.76M |
| Diamond Biotechnology | 501.49M |
| Radiant Innovation | 389.45M |
| S&S Healthcare Holding | 178.00M |
| PlexBio | 127.10M |